The collaboration between ten23 health and BD aims to commercialize the BD Libertas wearable injector for large-volume ...
FUROSCIX Auto-injector being developed as a complement to the FUROSCIX On-body Infusor Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug Application (sNDA) by year-end ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results